Hikma Pharmaceuticals (HKMPF) News Today → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free HKMPF Stock Alerts $22.33 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHikma Pharmaceuticals PLC goes ex dividend tomorrowmsn.com - March 20 at 5:15 AMOptimism around Hikma Pharmaceuticals (LON:HIK) delivering new earnings growth may be shrinking as stock declines 3.3% this past weekfinance.yahoo.com - March 18 at 7:54 AMHikma Pharmaceuticals PLC (HKMPF)finance.yahoo.com - February 27 at 4:02 PMDrugmaker Hikma expects profit to be slightly lower in 2024msn.com - February 22 at 7:56 AMHikma Pharma FY Profit Increasesmarkets.businessinsider.com - February 22 at 7:56 AMHikma Pharmaceuticals did not report suspicious opioid orders for 15 years, NC Attorney General Josh Stein saysmsn.com - February 1 at 6:51 PMHikma Pharmaceuticals Agrees in Principle to Pay up to $115M in US Opioid Settlementmarketwatch.com - February 1 at 1:51 PMAd firm Publicis, drugmaker Hikma settle US opioid cases for $500 millionfinance.yahoo.com - February 1 at 1:51 PMUPDATE 1-Ad firm Publicis, drugmaker Hikma settle US opioid cases for $500 millionfinance.yahoo.com - February 1 at 1:51 PMHikma Pharmaceuticals PLC's (LON:HIK) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?finance.yahoo.com - January 29 at 9:27 AMThe one-year decline in earnings might be taking its toll on Hikma Pharmaceuticals (LON:HIK) shareholders as stock falls 3.3% over the past weekfinance.yahoo.com - October 5 at 11:59 AMStocks Open Lower, Weighed Down by Rising Bond Yieldsfinance.yahoo.com - October 3 at 10:37 AMRakuten Medical and Hikma Sign Exclusive Licensing Agreement for Alluminox™ Platform Cancer Treatment in the Middle East and North Africafinance.yahoo.com - August 10 at 9:17 AMHikma Appoints Bill Larkins as President of Injectables Businessmarketwatch.com - August 9 at 4:33 AMHikma Ventures invests in Octave Bioscience, a precision care platform for Multiple Sclerosis and other neurodegenerative diseasesfinance.yahoo.com - July 26 at 4:38 PMSelling Hikma Pharmaceuticals After A 40% Share Price Gain In 7 Monthsmsn.com - May 6 at 10:01 AMHikma Pharmaceutical appoints Injectables lead Mishlawi as new CEOlse.co.uk - April 12 at 8:45 AMHikma Pharma Appoints Riad Mishlawi As CEO, Effective Sept. 1nasdaq.com - April 12 at 8:45 AMHikma Pharmaceuticals Appoints Riad Mishlawi CEOmarketwatch.com - April 12 at 8:45 AMHikma Pharma names Mishlawi as next CEOmsn.com - April 12 at 8:45 AMThose who invested in Hikma Pharmaceuticals (LON:HIK) five years ago are up 57%finance.yahoo.com - April 4 at 9:29 AMHikma Pharmaceuticals rises Thursday, still underperforms marketmarketwatch.com - March 18 at 2:39 PMHikma Pharmaceuticals falls Monday, still outperforms marketmarketwatch.com - March 15 at 10:26 PMHikma expands impact in Canada with launches of new sterile injectable medicinesfinance.yahoo.com - March 9 at 8:29 AMIs Hikma Pharmaceuticals PLC's (LON:HIK) Recent Stock Performance Influenced By Its Fundamentals In Any Way?finance.yahoo.com - February 27 at 4:48 AMHikma Pharmaceutical FY EPS 83.6cmarketwatch.com - February 23 at 4:18 AMHikma accuses Amarin of suppressing generic versions of heart pillfinance.yahoo.com - February 22 at 6:17 PMHikma Pharmaceuticals to Buy Generic Drug Maker Roxane for $2.65 Billionthestreet.com - December 28 at 6:51 PMHikma Pharmaceuticals Stock (OTC:HKMPF), Earnings Estimates, EPS, and Revenuebenzinga.com - November 5 at 10:45 PMCould The Market Be Wrong About Hikma Pharmaceuticals PLC (LON:HIK) Given Its Attractive Financial Prospects?finance.yahoo.com - September 20 at 3:24 AMHKMPF Hikma Pharmaceuticals PLCseekingalpha.com - September 10 at 12:01 PMHikma Pharmaceuticals PLC HKMPF Stock Chartmorningstar.com - September 9 at 3:48 PMHikma Pharmaceuticals PLC 2022 Q2 - Results - Earnings Call Presentationseekingalpha.com - August 5 at 4:38 PMHikma Pharma slides on lower generics guidanceproactiveinvestors.com - August 4 at 10:41 AMHikma Pharmaceuticals Plc 1H Rev $1.21Bmarketwatch.com - August 4 at 5:41 AMHikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 32% Above Their Intrinsic Value Estimatefinance.yahoo.com - June 10 at 2:27 AMHikma Pharma CEO Siggi Olafsson Resigns - Quick Factsmarkets.businessinsider.com - May 24 at 3:42 AMFTSE 100 soars after Wall St 'relief rally' and ahead of Bank of England decision but Hikma dropsproactiveinvestors.com.au - May 5 at 8:48 AMHikma Pharmaceuticals PLC: Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticalsfinanznachrichten.de - April 29 at 3:57 PMHikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticalsprnewswire.com - April 29 at 1:51 PMHikma Pharmaceuticals Gets Low Support for Re-Election of Patrick Butler at AGMmarketwatch.com - April 25 at 12:07 PMFTSE 100 flat but Wall Street makes a positive start despite Netflix flopproactiveinvestors.com.au - April 20 at 10:44 AMCross River Announces Completion of Inaugural Drill Campaign at the McVicar Gold Project, NW Ontariofinance.yahoo.com - April 13 at 8:53 AMIs Hikma Pharmaceuticals PLC's (LON:HIK) Stock's Recent Performance A Reflection Of Its Financial Health?finance.yahoo.com - April 13 at 2:17 AMHikma Ventures invests in Tact.ai, an AI-powered customer engagement platform for life sciences companiesfinance.yahoo.com - March 29 at 10:31 AMHikma Pharmaceutical FY EPS $1.807marketwatch.com - February 24 at 8:14 AMHikma Pharma FY21 Profit Down, Lifts Dividend; Stock Downmarkets.businessinsider.com - February 24 at 8:14 AMHikma Pharmaceuticals sales grow 9%, announces US$300mln share buybackproactiveinvestors.com - February 24 at 8:14 AMHikma Pharmaceuticals annual sales grow 9% but Generics guidance fails to meet expectationsproactiveinvestors.com - February 24 at 8:14 AM2 cheap UK stocks to buy for the rotation into valueuk.finance.yahoo.com - February 19 at 7:07 PM Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HKMPF and its competitors with MarketBeat's FREE daily newsletter. Email Address What is the 72-Hour Profit Surge? (Ad)One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge… Click here now to get all the details. HKMPF Media Mentions By Week HKMPF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HKMPF News Sentiment▼0.000.42▲Average Medical News Sentiment HKMPF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HKMPF Articles This Week▼00▲HKMPF Articles Average Week Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HKMPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Orion Oyj News Aspen Pharmacare News Zealand Pharma A/S News GN Store Nord A/S News Sino Biopharmaceutical News Aurora Cannabis News Amplifon News Sysmex News Eurofins Scientific News Sandoz Group News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:HKMPF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
